Compound ID | 3593
Class: Glycopeptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Enterococcus faecalis and Clostridium spp. |
| Description: | Natural product from Kibdelosporangiium aridum; natural analogues reported; shows inferior efficacy to vancomycin in mice infected with Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pyogenes but shows good protection when used as prophylaxis |
| Institute where first reported: | Smith Kline & French Laborcatories, Philadelphia, Pennsylvania 19101 USA |
| Year first mentioned: | 1985 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/86278229 |
| Citations: |
|